Brief Reports
Copyright ©2005 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2005; 11(40): 6381-6384
Published online Oct 28, 2005. doi: 10.3748/wjg.v11.i40.6381
Table 2 Effects of nucleosides on the cell cycle progression, caspas-3 activity and sFas-L content in HepG2 cells1
TreatmentControlInosineCytidineUridineThymidineAdenosineGaunosine
SubG1 (%)2.6±0.8a3.2±0.3a6.9±0.2a6.5±1.5a26.8±2.3a9.6±1.5a5.7±1.2a
G0/G1(%)67.7±1.1a69.2±0.1a74.1±1.3a84.8±2.6a54.4±1.8a64.8±1.4a68.0±1.9a
S (%)15.7±0.0a18.8±0.3a8.5±0.2a3.1±0.3a12.0±0.2a10.6±0.4a17.3±0.7a
G2/M (%)14.0±1.9a8.8±0.1a10.5±1.0a5.7±0.8a6.8±0.8a15.0±0.9a9.0±1.3a
Caspase-3 (%)2100±0a101±5a97±6a98±5a148±2a104±4a100±3a
sFas-L (pg/mL)0.11±0.01a0.14±0.01a0.08±0.03a0.15±0.03a0.17±0.02a0.15±0.07a0.10±0.03a